Inflammation is a part of the complex biological response of inflammatory cells to harmful stimuli, such as pathogens, irritants, or damaged cells. This inflammation has been linked to several chronic diseases including cancer, atherosclerosis, rheumatoid arthritis, and multiple sclerosis. Major biomarkers of inflammation include tumor necrosis factor, interleukins (IL)-1, IL-6, IL-8, chemokines, cyclooxygenase, 5-lipooxygenase, and C-reactive protein, all of which are regulated by the transcription factor nuclear factor-kappaB. Although examining inflammatory biomarkers in blood is a standard practice, its identification in saliva and/or urine is more convenient and non-invasive. In this review, we aim to (1) discuss the detection of these inflammatory biomarkers in urine and saliva; (2) advantages of using salivary and urinary inflammatory biomarkers over blood, while also weighing on the challenges and/or limitations of their use; (3) examine their role(s) in connection with diagnosis, prevention, treatment, and drug development for several chronic diseases with inflammatory consequences, including cancer; and (4) explore the use of innovative salivary and urine based biosensor strategies that may permit the testing of biomarkers quickly, reliably, and cost-effectively, in a decentralized setting.
YadavVRPrasadSSungBKannappanRAggarwalBB. Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer. Toxins2010; 2: 2428–66.
2.
AggarwalBBVijayalekshmiRVSungB. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res2009; 15: 425–30.
3.
PrasadSPhromnoiKYadavVRChaturvediMMAggarwalBB. Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Med2010; 76: 1044–63.
4.
PrasadSSungBAggarwalBB. Age-associated chronic diseases require age-old medicine: role of chronic inflammation. Prev Med2012; 54: S29–37.
5.
HeidlandAKlassenARutkowskiPBahnerU. The contribution of Rudolf Virchow to the concept of inflammation: what is still of importance?J Nephrol2006; 19: S102–9.
6.
AggarwalBBShishodiaSSandurSKPandeyMKSethiG. Inflammation and cancer: how hot is the link?Biochem Pharmacol2006; 72: 1605–21.
7.
LavrovskyYChatterjeeBClarkRARoyAK. Role of redox-regulated transcription factors in inflammation, aging and age-related diseases. Exp Gerontol2000; 35: 521–32.
8.
RahmanI. Oxidative stress, chromatin remodeling and gene transcription in inflammation and chronic lung diseases. J Biochem Mol Biol2003; 36: 95–109.
9.
AggarwalBBPrasadSReuterSKannappanRYadevVRParkBKimJHGuptaSCPhromnoiKSundaramCPrasadSChaturvediMMSungB. Identification of novel anti-inflammatory agents from ayurvedic medicine for prevention of chronic diseases: “reverse pharmacology” and “bedside to bench” approach. Curr Drug Targets2011; 12: 1595–653.
10.
AggarwalBBGuptaSCSungB. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br J Pharmacol2013; 169: 1672–92.
11.
AggarwalBBGehlotP. Inflammation and cancer: how friendly is the relationship for cancer patients?Curr Opin Pharmacol2009; 9: 351–69.
12.
MalamudD. Saliva as a diagnostic fluid. Dent Clin N Am2011; 55: 159–78.
13.
RahimMARahimZHAhmadWAHashimOH. Can saliva proteins be used to predict the onset of acute myocardial infarction among high-risk patients?Int J Med Sci2015; 12: 329–35.
14.
BeretovJWasingerVCGrahamPHMillarEKKearsleyJHLiY. Proteomics for breast cancer urine biomarkers. Adv Clin Chem2014; 63: 123–67.
15.
CeccatoFBarbotMZilioMFerasinSOcchiGDanieleAMazzocutSIacoboneMBetterleCManteroFScaroniC. Performance of salivary cortisol in the diagnosis of Cushing’s syndrome, adrenal incidentaloma, and adrenal insufficiency. Eur J Endocrinol2013; 169: 31–6.
16.
FransenKVermoesenTBeelaertGMentenJHutseVWoutersKPlatteauTFlorenceE. Using conventional HIV tests on oral fluid. J Virol Meth2013; 194: 46–51.
17.
KefalidesNAMonboisseJCBellonGOhnoNZiaieZShahanTA. Suppression of tumor cell growth by type IV collagen and a peptide from the NC1 domain of the alpha 3(IV) chain. Medicina1999; 59: 553–553.
18.
StreckfusCBiglerLTucciMThigpenJT. A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer Invest2000; 18: 101–9.
19.
ChaiRLGrandisJR. Advances in molecular diagnostics and therapeutics in head and neck cancer. Curr Treat Options Oncol2006; 7: 3–11.
20.
RobinsSP. Collagen crosslinks in metabolic bone disease. Acta Orthopaed Scand Suppl1995; 266: 171–5.
21.
KamelSBrazierMNeriVPicardCSamsonLDesmetGSebertJL. Multiple molecular forms of pyridinolines cross-links excreted in human urine evaluated by chromatographic and immunoassay methods. J Bone Miner Res1995; 10: 1385–92.
22.
MlcochovaHHezovaRStanikMSlabyO. Urine microRNAs as potential noninvasive biomarkers in urologic cancers. Urol Oncol2014; 32: 41 e1–9.
23.
Sysi-AhoMErmolovAGopalacharyuluPVTripathiASeppanen-LaaksoTMaukonenJMattilaIRuohonenSTVähätaloLYetukuriLHärkönenTLindforsENikkiläJIlonenJSimellOSaarelaMKnipMKaskiSSavontausEOrešičM. Metabolic regulation in progression to autoimmune diabetes. PLoS Comput Biol2011; 7: e1002257–e1002257.
24.
BatheOFShaykhutdinovRKopciukKWeljieAMMcKayASutherlandFRDixonEDunseNSotiropoulosDVogelHJ. Feasibility of identifying pancreatic cancer based on serum metabolomics. Cancer Epidemiol Biomarkers Prev2011; 20: 140–7.
25.
RhodusNLChengBMyersSMillerLHoVOndreyF. The feasibility of monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog2005; 44: 77–82.
26.
KatakuraAKamiyamaITakanoNShibaharaTMuramatsuTIshiharaKTakagiRShounoT. Comparison of salivary cytokine levels in oral cancer patients and healthy subjects. Bull Tokyo Dent Coll2007; 48: 199–203.
27.
PickeringVJordanRCSchmidtBL. Elevated salivary endothelin levels in oral cancer patients–a pilot study. Oral Oncol2007; 43: 37–41.
28.
MizukawaNSugiyamaKFukunagaJUenoTMishimaKTakagiSSugaharaT. Defensin-1, a peptide detected in the saliva of oral squamous cell carcinoma patients. Anticancer Res1998; 18: 4645–9.
29.
MetgudRPatelS. Serum and salivary levels of albumin as diagnostic tools for oral pre-malignancy and oral malignancy. Biotech Histochem2014; 89: 8–13.
30.
NaglerRBaharGShpitzerTFeinmesserR. Concomitant analysis of salivary tumor markers–a new diagnostic tool for oral cancer. Clin Cancer Res2006; 12: 3979–84.
31.
AlmadoriGBussuFGalliJLimongelliAPersichilliSZappacostaBMinucciAPaludettiGGiardinaB. Salivary glutathione and uric acid levels in patients with head and neck squamous cell carcinoma. Head Neck2007; 29: 648–54.
32.
DowlingPWormaldRMeleadyPHenryMCurranAClynesM. Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis. J Proteom2008; 71: 168–75.
33.
HuSArellanoMBoontheungPWangJZhouHJiangJElashoffDWeiRLooJAWongDT. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res2008; 14: 6246–52.
34.
WarnakulasuriyaSSoussiTMaherRJohnsonNTavassoliM. Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients. J Pathol2000; 192: 52–7.
35.
JessieKJayapalanJJOngKCAbdul RahimZHZainRMWongKTHashimOH. Aberrant proteins in the saliva of patients with oral squamous cell carcinoma. Electrophoresis2013; 34: 2495–502.
36.
YangSFChenMKHsiehYSChungTTHsiehYHLinCWSuJLTsaiMHTangCH. Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells. J Biol Chem2010; 285: 29808–16.
37.
WangJXiLGoodingWGodfreyTEFerrisRL. Chemokine receptors 6 and 7 identify a metastatic expression pattern in squamous cell carcinoma of the head and neck. Adv Otorhinolaryngol2005; 62: 121–33.
38.
FarmerRWRichtsmeierWJScherRL. Identification of sialyl Lewis-x in squamous cell carcinoma of the head and neck. Head Neck1998; 20: 726–31.
39.
VlkovaBStankoPMinarikGTothovaLSzemesTBanasovaLNovotňákováDHodosyJCelecP. Salivary markers of oxidative stress in patients with oral premalignant lesions. Arch Oral Biol2012; 57: 1651–6.
40.
GoncalvesASArantesDABernardesVFJaegerFSilvaJMSilvaTAguiarMCBatistaAC. Immunosuppressive mediators of oral squamous cell carcinoma in tumour samples and saliva. Hum Immunol2015; 76: 52–8.
41.
MuAKChanYSKangSSAzmanSNZainRBChaiWLChenY. Detection of host-specific immunogenic proteins in the saliva of patients with oral squamous cell carcinoma. J Immunoassay Immunochem2014; 35: 183–93.
42.
WangQGaoPWangXDuanY. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma. Clin Chim Acta2014; 427: 79–85.
43.
SalazarCNagadiaRPanditPCooper-WhiteJBanerjeeNDimitrovaNComanWBPunyadeeraC. A novel saliva-based microRNA biomarker panel to detect head and neck cancers. Cell Oncol2014; 37: 331–8.
44.
NavarroMAMesiaRDiez-GibertORuedaAOjedaBAlonsoMC. Epidermal growth factor in plasma and saliva of patients with active breast cancer and breast cancer patients in follow-up compared with healthy women. Breast Cancer Res Treat1997; 42: 83–6.
45.
PinkRSimekJVondrakovaJFaberEMichlPPazderaJIndrakK. Saliva as a diagnostic medium. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia2009; 153(2): 103–10.
46.
JenzanoJWCourtsNFTimkoDALundbladRL. Levels of glandular kallikrein in whole saliva obtained from patients with solid tumors remote from the oral cavity. J Dent Res1986; 65: 67–70.
47.
SchapherMWendlerOGroschlMSchaferRIroHZenkJ. Salivary leptin as a candidate diagnostic marker in salivary gland tumors. Clin Chem2009; 55: 914–22.
48.
TrubnikovGASukharevAEUklistaiaTAOrlovaEA. [Clinico-diagnostic role of ferritin and lactoferrin assays in benign and malignant affections of lungs and pleura]. Klin Med1998; 76: 21–6.
49.
FineDHMarkowitzKFurgangDFairlieKFerrandizJNasriCMcKiernanMDonnellyRGunsolleyJ. Macrophage inflammatory protein-1alpha: a salivary biomarker of bone loss in a longitudinal cohort study of children at risk for aggressive periodontal disease?J Periodontol2009; 80: 106–13.
50.
Al-SabbaghMAlladahALinYKryscioRJThomasMVEbersoleJLMillerCS. Bone remodeling-associated salivary biomarker MIP-1alpha distinguishes periodontal disease from health. J Periodontal Res2012; 47: 389–95.
51.
GuptaMChaturvediRJainA. Role of monocyte chemoattractant protein-1 (MCP-1) as an immune-diagnostic biomarker in the pathogenesis of chronic periodontal disease. Cytokine2013; 61: 892–7.
52.
RaiBKharbSJainRAnandSC. Biomarkers of periodontitis in oral fluids. J Oral Sci2008; 50: 53–6.
53.
SundarNMKrishnanVKrishnarajSHemalathaVTAlamMN. Comparison of the salivary and the serum nitric oxide levels in chronic and aggressive periodontitis: a biochemical study. J Clin Diagn Res JCDR2013; 7: 1223–7.
54.
BathenaSPHuangJNunnMEMiyamotoTParrishLCLangMSMcVaneyTPToewsMLCerutisDRAlnoutiY. Quantitative determination of lysophosphatidic acids (LPAs) in human saliva and gingival crevicular fluid (GCF) by LC-MS/MS. J Pharm Biomed Anal2011; 56: 402–7.
55.
BostanciNOzturkVOEmingilGBelibasakisGN. Elevated oral and systemic levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in periodontitis. J Dent Res2013; 92: 161–5.
56.
YoonAJChengBPhiliponeETurnerRLamsterIB. Inflammatory biomarkers in saliva: assessing the strength of association of diabetes mellitus and periodontal status with the oral inflammatory burden. J Clin Periodontol2012; 39: 434–40.
57.
EbersoleJLSchusterJLStevensJDawsonD3rdKryscioRJLinYThomasMVMillerCS. Patterns of salivary analytes provide diagnostic capacity for distinguishing chronic adult periodontitis from health. J Clin Immunol2013; 33: 271–9.
58.
GlimvallPWickstromCJanssonH. Elevated levels of salivary lactoferrin, a marker for chronic periodontitis?J Periodontal Res2012; 47: 655–60.
59.
SezerEDAksuKCaglayanOKeserGKarabulutGErcanG. DNA damage and its relationship with other oxidative stress parameters in Behcet’s disease. Rheumatol Int2012; 32: 217–22.
60.
ChoiYJHeoSHLeeJMChoJY. Identification of azurocidin as a potential periodontitis biomarker by a proteomic analysis of gingival crevicular fluid. Proteome Sci2011; 9: 42–42.
61.
SalazarMGJehmlichNMurrADhopleVMHoltfreterBHammerEVölkerUKocherT. Identification of periodontitis associated changes in the proteome of whole human saliva by mass spectrometric analysis. J Clin Periodontol2013; 40: 825–32.
62.
Mendoza-NunezVMHernandez-MonjarazBSantiago-OsorioEBetancourt-RuleJMRuiz-RamosM. Tai Chi exercise increases SOD activity and total antioxidant status in saliva and is linked to an improvement of periodontal disease in the elderly. Oxid Med Cell Longevity2014; 2014: 603853–603853.
63.
BaltaciogluEYuvaPAydinGAlverAKahramanCKarabulutEAkalınFA. Lipid peroxidation levels and total oxidant/antioxidant status in serum and saliva from patients with chronic and aggressive periodontitis. Oxidative stress index: a new biomarker for periodontal disease?J Periodontol2014; 85: 1432–41.
64.
ZhangWYLiuWZhouYMShenXMWangYFTangGY. Altered microRNA expression profile with miR-27b down-regulation correlated with disease activity of oral lichen planus. Oral Dis2012; 18: 265–70.
65.
LiuWDanHWangZJiangLZhouYZhaoMChenQZengX. IFN-gamma and IL-4 in saliva of patients with oral lichen planus: a study in an ethnic Chinese population. Inflammation2009; 32: 176–81.
66.
JanardhanamSBPrakasamSSwaminathanVTKodumudiKNZuntSLSrinivasanM. Differential expression of TLR-2 and TLR-4 in the epithelial cells in oral lichen planus. Arch Oral Biol2012; 57: 495–502.
67.
LiuWZHeMJLongLMuDLXuMSXingXZengXLiaoGDanHXChenQM. Interferon-gamma and interleukin-4 detected in serum and saliva from patients with oral lichen planus. Int J Oral Sci2014; 6: 22–6.
68.
GornowiczABielawskaABielawskiKGrabowskaSZWojcickaAZalewskaMMaciorkowskaE. Pro-inflammatory cytokines in saliva of adolescents with dental caries disease. Ann Agric Environ Med AAEM2012; 19: 711–6.
69.
ZhaoABlackburnCChinJSrinivasanM. Soluble toll like receptor 2 (TLR-2) is increased in saliva of children with dental caries. BMC Oral Health2014; 14: 108–108.
70.
HegdeMNHegdeNDAshokAShettyS. Biochemical indicators of dental caries in saliva: an in vivo study. Caries Res2014; 48: 170–3.
71.
Gabryel-PorowskaHGornowiczABielawskaAWojcickaAMaciorkowskaEGrabowskaSZBielawskiK. Mucin levels in saliva of adolescents with dental caries. Med Sci Monit2014; 20: 72–7.
72.
Zidverc-TrajkovicJStanimirovicDObrenovicRTajtiJVecseiLGardiJNémethJMijajlovicMSternicNJankovicL. Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome. J Oral Pathol Med2009; 38: 29–33.
73.
Hernandez-MolinaGMichel-PeregrinaMHernandez-RamirezDFSanchez-GuerreroJLlorenteL. Chemokine saliva levels in patients with primary Sjogren’s syndrome, associated Sjogren’s syndrome, pre-clinical Sjogren’s syndrome and systemic autoimmune diseases. Rheumatology2011; 50: 1288–92.
74.
KramerJMKlimatchevaERothsteinTL. CXCL13 is elevated in Sjogren’s syndrome in mice and humans and is implicated in disease pathogenesis. J Leukoc Biol2013; 94: 1079–89.
75.
CuidaMHalseAKJohannessenACTynningTJonssonR. Indicators of salivary gland inflammation in primary Sjogren’s syndrome. Eur J Oral Sci1997; 105: 228–33.
76.
CicciaFGugginoGRizzoAFerranteARaimondoSGiardinaADieliFCampisiGAlessandroRTrioloG. Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren’s syndrome. Ann Rheum Dis2012; 71: 295–301.
77.
DelaleuNMydelPKweeIBrunJGJonssonMVJonssonR. High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjogren’s syndrome. Arthritis Rheumatol2015; 67: 1084–95.
78.
SzczeklikKOwczarekDPytko-PolonczykJKesekBMachTH. Proinflammatory cytokines in the saliva of patients with active and non-active Crohn’s disease. Pol Arch Med Wewn2012; 122: 200–8.
79.
DeSantisASDiezRouxAVHajatAAielloAEGoldenSHJennyNSSeemanTESheaS. Associations of salivary cortisol levels with inflammatory markers: the Multi-Ethnic Study of Atherosclerosis. Psychoneuroendocrinology2012; 37: 1009–18.
80.
Al-NimerMSMshatatSFAbdullaHI. Saliva alpha-synuclein and a high extinction coefficient protein: a novel approach in assessment biomarkers of Parkinson’s disease. N Am J Med Sci2014; 6: 633–7.
81.
ThormanRLundahlJYucel-LindbergTHylanderB. Inflammatory cytokines in saliva: early signs of metabolic disorders in chronic kidney disease. A controlled cross-sectional study. Oral Surg Oral Med Oral Pathol Oral Radiol Endodont2010; 110: 597–604.
82.
EisenbergEShtahlSGellerRReznickAZSharfORavbinovichMErenreichANaglerRM. Serum and salivary oxidative analysis in complex regional pain syndrome. Pain2008; 138: 226–32.
83.
RezaieAKhalajSShabihkhaniMNikfarSZamaniMJMohammadiradADaryaniNEAbdollahiM. Study on the correlations among disease activity index and salivary transforming growth factor-beta 1 and nitric oxide in ulcerative colitis patients. Ann N Y Acad Sci2007; 1095: 305–14.
84.
BorderMBSchwartzSCarlsonJDibbleCFKohltfarberHOffenbacherSUseJBBencharitS. Exploring salivary proteomes in edentulous patients with type 2 diabetes. Mol Biosyst2012; 8: 1304–10.
85.
Mook-KanamoriDOSelimMMTakiddinAHAl-HomsiHAl-MahmoudKAAl-ObaidliAZirieMARoweJYousriNAKarolyEDKocherTSekkal GherbiWChidiacOMMook-KanamoriMJAbdul KaderSAl MuftahWAMcKeonCSuhreK. 1,5-Anhydroglucitol in saliva is a noninvasive marker of short-term glycemic control. J Clin Endocrinol Metab2014; 99: E479–83.
86.
Zalewska-SzajdaBDariusz SzajdaSWaszkiewiczNChojnowskaSGoscikELebkowskaUKępkaABossowskiAZalewskaAJanicaJZwierzKŁadnyJRWaszkielD. Activity of N-acetyl-beta-D-hexosaminidase in the saliva of children with type 1 diabetes. Postepy Hig Med Dosw2013; 67: 996–9.
87.
SuHVellyAMSalahMHBenarrochMTrifiroMSchipperHMGornitskyM. Altered redox homeostasis in human diabetes saliva. J Oral Pathol Med2012; 41: 235–41.
88.
Al-RawiNH. Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics. Diabetes Vasc Dis Res2011; 8: 22–8.
89.
SoellMFekiAHannigMSanoHPingetMSelimovicD. Chromogranin A detection in saliva of type 2 diabetes patients. Bosnian J Basic Med Sci2010; 10: 2–8.
90.
AranaCCutandoAFerreraMJGomez-MorenoGWorfCVBolanosMJEscamesGAcuña-CastroviejoD. Parameters of oxidative stress in saliva from diabetic and parenteral drug addict patients. J Oral Pathol Med2006; 35: 554–9.
91.
YoonMSJankowskiVMontagSZidekWHenningLSchluterHTepelMJankowskiJ. Characterisation of advanced glycation endproducts in saliva from patients with diabetes mellitus. Biochem Biophys Res Commun2004; 323: 377–81.
92.
MatiasIGatta-CherifiBTabarinAClarkSLeste-LasserreTMarsicanoGPiazzaPVCotaD. Endocannabinoids measurement in human saliva as potential biomarker of obesity. PloS One2012; 7: e42399–e42399.
93.
OzcakaOCeyhanBOAkcaliABicakciNLappinDFBuduneliN. Is there an interaction between polycystic ovary syndrome and gingival inflammation?J Periodontol2012; 83: 1529–37.
94.
ResendeRGCorreia-SilvaJDSilvaTAXavierSGBittencourtHGomezRSAbreuMH. Saliva and blood interferon gamma levels and IFNG genotypes in acute graft-versus-host disease. Oral Dis2012; 18: 816–22.
95.
DevicIShiMSchubertMMLloidMIzutsuKTPanCMissaghiMMortonTHManclLAZhangJPreslandRB. Proteomic analysis of saliva from patients with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant2014; 20: 1048–55.
96.
RaoNLShettySUpadhyayaKLoboRMPKedilayaECPrasadHPG. Salivary C-reactive protein in Hashimoto’s thyroiditis and subacute thyroiditis. Int J Inflam2010; 2010: 514659–514659.
97.
de SousaRTZarateCAJrZanettiMVCostaACTalibLLGattazWFMachado-VieiraR. Oxidative stress in early stage bipolar disorder and the association with response to lithium. J Psych Res2014; 50: 36–41.
98.
CohenMKhalailaR. Saliva pH as a biomarker of exam stress and a predictor of exam performance. J Psychosom Res2014; 77: 420–5.
99.
EscribanoDGutierrezAMFuentes-RubioMCeronJJ. Saliva chromogranin A in growing pigs: a study of circadian patterns during daytime and stability under different storage conditions. Vet J2014; 199: 355–9.
100.
van HollandBJFrings-DresenMHSluiterJK. Measuring short-term and long-term physiological stress effects by cortisol reactivity in saliva and hair. Int Arch Occup Environ Health2012; 85: 849–52.
101.
GolshiriPPourabdianSNajimiAZadehHMHasheminiaJ. Job stress and its relationship with the level of secretory IgA in saliva: a comparison between nurses working in emergency wards and hospital clerks. J Pak Med Assoc2012; 62: S26–30.
102.
AydinSAydinSKobatMAKalayciMErenMNYilmazMKulogluTGulESecenOAlatasODBaydasA. Decreased saliva/serum irisin concentrations in the acute myocardial infarction promising for being a new candidate biomarker for diagnosis of this pathology. Peptides2014; 56: 141–5.
103.
PhalaneKGKrielMLoxtonAGMenezesAStanleyKvan der SpuyGDWalzlGChegouNN. Differential expression of host biomarkers in saliva and serum samples from individuals with suspected pulmonary tuberculosis. Mediators inflamm2013; 2013: 981984–981984.
104.
RubioMCGonzalezPMRamosCLewinPGFriedmanSMPuntaruloSNicolosiLN. Oxidative stress assessed in saliva from patients with acute myocardial infarction. A preliminary study. Acta Odontol Latinoam2013; 26: 116–20.
105.
TokerAAribasAYerlikayaFHTasyurekEAkbugaK. Serum and saliva levels of ischemia-modified albumin in patients with acute myocardial infarction. J Clin Lab Anal2013; 27: 99–104.
106.
Mirzaii-DizgahIHejaziSFRiahiESalehiMM. Saliva-based creatine kinase MB measurement as a potential point-of-care testing for detection of myocardial infarction. Clin Oral Invest2012; 16: 775–9.
107.
CavasLArpinarPYurdakocK. Possible interactions between antioxidant enzymes and free sialic acids in saliva: a preliminary study on elite judoists. Int J Sports Med2005; 26: 832–5.
108.
FoleyJD3rdSneedJDSteinhublSRKolasaJEbersoleJLLinYKryscioRJMcDevittJTCampbellCLMillerCS. Oral fluids that detect cardiovascular disease biomarkers. Oral Surg Oral Med Oral Pathol Oral Radiol2012; 114: 207–14.
109.
VietCTJordanRCSchmidtBL. DNA promoter hypermethylation in saliva for the early diagnosis of oral cancer. J Calif Dental Assoc2007; 35: 844–9.
110.
LallemantBEvrardACombescureCChapuisHChambonGRaynalCReynaudCSabraOJoubertDHollandeFLallemantJGLumbrosoSBrouilletJP. Clinical relevance of nine transcriptional molecular markers for the diagnosis of head and neck squamous cell carcinoma in tissue and saliva rinse. BMC Cancer2009; 9: 370–370.
111.
el-MiedanyYMel-HadySMel-BaddinMA. Validity of the saliva ferning test for the diagnosis of dry mouth in Sjogren’s syndrome. Rev Rhumat1999; 66: 73–8.
112.
HuSVissinkAArellanoMRoozendaalCZhouHKallenbergCGWongDT. Identification of autoantibody biomarkers for primary Sjogren’s syndrome using protein microarrays. Proteomics2011; 11: 1499–507.
113.
EsmailiNMortazaviHKamyab-HesariKAghazadehNDaneshpazhoohMKhaniSChams-DavatchiC. Diagnostic accuracy of BP180 NC16a and BP230-C3 ELISA in serum and saliva of patients with bullous pemphigoid. Clin Exp Dermatol2015; 40: 324–30.
114.
BelstromDFiehnNENielsenCHKirkbyNTwetmanSKlepac-CerajVPasterBJHolmstrupP. Differences in bacterial saliva profile between periodontitis patients and a control cohort. J Clin Periodontol2014; 41: 104–12.
115.
Radzol AR, Lee KY, Mansor W. Nonstructural protein 1 characteristic peak from NS1-saliva mixture with surface-enhanced Raman spectroscopy. In: Conference proceedings: annual international conference of the IEEE engineering in medicine and biology society IEEE engineering in medicine and biology society annual conference. 03--07 July 2013, Osaka, Japan, pp.2396–9.
116.
PhumeeAKraivichianKChusriSNoppakunNVibhagoolASanprasertVTampanyaVWildeHSiriyasatienP. Detection of Leishmania siamensis DNA in saliva by polymerase chain reaction. Am J Trop Med Hyg2013; 89: 899–905.
117.
Holm-HansenCNyombiBNyindoM. Saliva-based HIV testing among secondary school students in Tanzania using the OraQuick rapid HIV1/2 antibody assay. Ann N Y Acad Sci2007; 1098: 461–6.
118.
MellershAClarkAHafizS. Inhibition of Neisseria gonorrhoeae by normal human saliva. Br J Venereal Dis1979; 55: 20–3.
119.
Garcia-BaqueroRPuertaPBeltranMAlvarezMSacristanRAlvarez-OssorioJLSánchez-CarbayoM. Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study. J Urol2013; 190: 723–30.
120.
TomitaYMiyakeNYamanakaS. Lipids in human parotid saliva with regard to caries experience. J Oleo Sci2008; 57: 115–21.
121.
AbikoYNishimuraMKakuT. Defensins in saliva and the salivary glands. Med Electron Microsc2003; 36: 247–52.
122.
WoltgensJHEttyEJGruythuysenRJGeraetsWG. Influence of fluoride in saliva during the early cariogenic changes in the enamel of boys and girls. ASDC J Dent Child1995; 62: 192–6.
123.
BalMVOlgunAAbasliDOzdemirAKursakliogluHGoktepeASKurtÍ. The effect of nonsurgical periodontal treatment on serum and saliva chitotriosidase activities in patients with periodontitis and coronary artery disease. Ther Clin Risk Manage2015; 11: 53–8.
124.
NovakovicNCakicSTodorovicTRaicevicBADozicIPetrovicVPerunovićNGostovićSSSretenovićJKColakE. Antioxidative status of saliva before and after non-surgical periodontal treatment. Srp Arh Celok Lek2013; 141: 163–8.
125.
GuentschAPreshawPMBremer-StreckSKlingerGGlockmannESiguschBW. Lipid peroxidation and antioxidant activity in saliva of periodontitis patients: effect of smoking and periodontal treatment. Clin Oral Invest2008; 12: 345–52.
126.
GorskaRNedzi-GoraM. The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis. Arch Immunol Ther Exp2006; 54: 419–26.
127.
JentschHSievertYGockeR. Lactoferrin and other markers from gingival crevicular fluid and saliva before and after periodontal treatment. J Clin Periodontol2004; 31: 511–4.
128.
MalhotraSL. New approaches to the pathogenesis of peptic ulcer based on the protective action of saliva with special reference to roughage, vegetable fibre and fermented milk products. Med Hypotheses1978; 4: 1–14.
129.
SilvaMJReidyJASamandarEHerbertARNeedhamLLCalafatAM. Detection of phthalate metabolites in human saliva. Arch Toxicol2005; 79: 647–52.
130.
AdamDJMilneAAEvansSMRoulstonJELeeAJRuckleyCVBradburyAW. Serum amylase isoenzymes in patients undergoing operation for ruptured and non-ruptured abdominal aortic aneurysm. J Vasc Surg1999; 30: 229–35.
131.
MargelDPevsner-FischerMBanielJYossepowitchOCohenIR. Stress proteins and cytokines are urinary biomarkers for diagnosis and staging of bladder cancer. Eur Urol2011; 59: 113–9.
132.
UrquidiVKimJChangMDaiYRosserCJGoodisonS. CCL18 in a multiplex urine-based assay for the detection of bladder cancer. PloS One2012; 7: e37797–e37797.
133.
GogalicSSauerUDopplerSPreiningerC. Bladder cancer biomarker array to detect aberrant levels of proteins in urine. The Analyst2015; 140: 724–35.
134.
ZhangGGomes-GiacoiaEDaiYLawtonAMiyakeMFuruyaHGoodisonSRosserCJ. Validation and clinicopathologic associations of a urine-based bladder cancer biomarker signature. Diagn Pathol2014; 9: 200–200.
135.
ShichkinVPLonADYugrinovaLGGrinevichYABelovaOBBerezhnayaNMAkalovichSPashkovaOVoitenokNN. TNF receptor p55 and IL-8(72) and IL-8(77) isoforms: blood and urine levels in breast cancer patients. J Immunotoxicol2009; 6: 235–42.
136.
Il’yasovaDKennedyKSpasojevicIWangFTolunAABaseKYoungSPKelly MarcomPMarksJMillingtonDSDewhirstMW. Individual responses to chemotherapy-induced oxidative stress. Breast Cancer Res Treat2011; 125: 583–9.
137.
Faupel-BadgerJMFuhrmanBJXuXFalkRTKeeferLKVeenstraTDHooverRNZieglerRG. Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens. Cancer Epidemiol Biomarkers Prev2010; 19: 292–300.
138.
XuXVeenstraTDFoxSDRomanJMIssaqHJFalkRSaavedraJEKeeferLKZieglerRG. Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem2005; 77: 6646–54.
139.
WooHMKimKMChoiMHJungBHLeeJKongGNamSJKimSBaiSWChungBC. Mass spectrometry based metabolomic approaches in urinary biomarker study of women’s cancers. Clin Chim Acta2009; 400: 63–9.
140.
NamHChungBCKimYLeeKLeeD. Combining tissue transcriptomics and urine metabolomics for breast cancer biomarker identification. Bioinformatics2009; 25: 3151–7.
141.
ChoSHJungBHLeeSHLeeWYKongGChungBC. Direct determination of nucleosides in the urine of patients with breast cancer using column-switching liquid chromatography-tandem mass spectrometry. Biomed Chromatogr2006; 20: 1229–36.
142.
HsuWYLinWDTsaiYLinCTWangHCJengLBLeeCCLinYCLaiCCTsaiFJ. Analysis of urinary nucleosides as potential tumor markers in human breast cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry. Clin Chim Acta2011; 412: 1861–6.
143.
ByunJALeeSHJungBHChoiMHMoonMHChungBC. Analysis of polyamines as carbamoyl derivatives in urine and serum by liquid chromatography-tandem mass spectrometry. Biomed Chromatogr2008; 22: 73–80.
144.
FengCWuZGuoTJiangHGuanMZhangYWenHDingQ. BLCA-4 expression is related to MMP-9, VEGF, IL-1alpha and IL-8 in bladder cancer but not to PEDF, TNF-alpha or angiogenesis. Pathol Biol2012; 60: e36–40.
145.
LeeHLEomHSYunTKimHJParkWSNamBHMoon-WooSLeeDHKongSY. Serum and urine levels of interleukin-8 in patients with non-Hodgkin’s lymphoma. Cytokine2008; 43: 71–5.
146.
FujitaKEwingCMIsaacsWBPavlovichCP. Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status. Int J Cancer2011; 129: 424–32.
147.
KorzeniewskiNTosevGPahernikSHadaschikBHohenfellnerMDuensingS. Identification of cell-free microRNAs in the urine of patients with prostate cancer. Urol Oncol2015; 33: 16 e7–22.
148.
SomATuSMLiuJWangXQiaoWLogothetisCCornPG. Response in bone turnover markers during therapy predicts overall survival in patients with metastatic prostate cancer: analysis of three clinical trials. Br J Cancer2012; 107: 1547–53.
149.
SapreNHongMKMacintyreGLewisHKowalczykACostelloAJCorcoranNMHovensCM. Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer. PloS One2014; 9: e91729–e91729.
150.
ParkSLCarmellaSGMingXVielguthEStramDOLe MarchandLHechtSS. Variation in levels of the lung carcinogen NNAL and its glucuronides in the urine of cigarette smokers from five ethnic groups with differing risks for lung cancer. Cancer Epidemiol Biomarkers Prev2015; 24: 561–9.
151.
LiuBCZhangLLvLLWangYLLiuDGZhangXL. Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease. Am J Nephrol2006; 26: 483–90.
152.
NiJHuangHQLuLLZhengMLiuBC. Influence of irbesartan on the urinary excretion of cytokines in patients with chronic kidney disease. Chin Med J2012; 125: 1147–52.
153.
Idasiak-PiechockaIOkoAPawliczakEKaczmarekECzekalskiS. Urinary excretion of soluble tumour necrosis factor receptor 1 as a marker of increased risk of progressive kidney function deterioration in patients with primary chronic glomerulonephritis. Nephrol Dial Transplant2010; 25: 3948–56.
154.
SuenJLLiuCCLinYSTsaiYFJuoSHChouYH. Urinary chemokines/cytokines are elevated in patients with urolithiasis. Urol Res2010; 38: 81–7.
155.
NassirpourRMathurSGosinkMMLiYShoiebAMWoodJO’NeilSPHomerBLWhiteleyLO. Identification of tubular injury microRNA biomarkers in urine: comparison of next-generation sequencing and qPCR-based profiling platforms. BMC Genomics2014; 15: 485–485.
156.
HuybrechtsBMartinsJCDebongniePUhligSCallebautA. Fast and sensitive LC-MS/MS method measuring human mycotoxin exposure using biomarkers in urine. Arch Toxicol2015; 89: 1993–2005.
157.
SerenoJNunesSRodrigues-SantosPValaHRocha-PereiraPFernandesJSantos-SilvaATeixeiraFReisF. Conversion to sirolimus ameliorates cyclosporine-induced nephropathy in the rat: focus on serum, urine, gene, and protein renal expression biomarkers. BioMed Res Int2014; 2014: 576929–576929.
158.
LiuDHuangPLiXGeMLuoGHeiZ. Using inflammatory and oxidative biomarkers in urine to predict early acute kidney injury in patients undergoing liver transplantation. Biomarkers2014; 19: 424–9.
159.
GuLWangXZhangYJiangYLuHBiKChenX. Determination of 12 potential nephrotoxicity biomarkers in rat serum and urine by liquid chromatography with mass spectrometry and its application to renal failure induced by Semen Strychni. J Separation Sci2014; 37: 1058–66.
160.
StubendorffBFinkeSWalterMKniemeyerOvon EggelingFGruschwitzTSteinerTOttUWolfGWunderlichHJunkerK. Urine protein profiling identified alpha-1-microglobulin and haptoglobin as biomarkers for early diagnosis of acute allograft rejection following kidney transplantation. World J Urol2014; 32: 1619–24.
161.
ParikhCRDahlNKChapmanABBostJEEdelsteinCLComerDMeltnerRTianXGranthamJJSomloS. Evaluation of urine biomarkers of kidney injury in polycystic kidney disease. Kidney Int2012; 81: 784–90.
162.
MeijerEBoertienWENautaFLBakkerSJvan OeverenWRookMvan der JagtEJvan GoorHPetersDJNavisGde JongPEGansevoortRT. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis. Am J Kidney Dis2010; 56: 883–95.
163.
WasilewskaAZoch-ZwierzWTaranta-JanuszKKolodziejczykZ. Urinary monocyte chemoattractant protein-1 excretion in children with glomerular proteinuria. Scand J Urol Nephrol2011; 45: 52–9.
164.
Sola-Del ValleDAMohanSChengJTParagasNASiseMED’AgatiVDBaraschJ. Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy. Nephrol Dial Transplant2011; 26: 2387–90.
165.
TorresMEGoncalvesLLBronzeMRSantosAPBatoreuMCMateusML. Alternative biomarkers of n-hexane exposure: characterization of aminoderived pyrroles and thiol-pyrrole conjugates in urine of rats exposed to 2,5-hexanedione. Toxicol Lett2014; 224: 54–63.
166.
GhanbariHGhanbariKBeheshtiIMunzarMVasauskasAAverbackP. Biochemical assay for AD7C-NTP in urine as an Alzheimer’s disease marker. J Clin Lab Analy1998; 12: 285–8.
167.
WangCCuiYYangJZhangJYuanDWeiYLiYDuoYLiSZhuWZhengL. Combining serum and urine biomarkers in the early diagnosis of mild cognitive impairment that evolves into Alzheimer’s disease in patients with the apolipoprotein E 4 genotype. Biomarkers2015; 20: 84–8.
168.
FukuharaKOhnoAOtaYSenooYMaekawaKOkudaHKuriharaMOkunoANiidaSSaitoYTakikawaO. NMR-based metabolomics of urine in a mouse model of Alzheimer’s disease: identification of oxidative stress biomarkers. J Clin Biochem Nutr2013; 52: 133–8.
169.
ZhangCNestorovaGRissmanRAFengJ. Detection and quantification of 8-hydroxy-2’-deoxyguanosine in Alzheimer’s transgenic mouse urine using capillary electrophoresis. Electrophoresis2013; 34: 2268–74.
170.
TakataMNakashimaMTakeharaTBabaHMachidaKAkitakeYOnoKHosokawaMTakahashiM. Detection of amyloid beta protein in the urine of Alzheimer’s disease patients and healthy individuals. Neurosci Lett2008; 435: 126–30.
171.
KimKMJungBHPaengKJKimIChungBC. Increased urinary F(2)-isoprostanes levels in the patients with Alzheimer’s disease. Brain Res Bull2004; 64: 47–51.
172.
ConnollyJSiderowfAClarkCMMuDPraticoD. F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired Parkinson disease patients. Cogn Behav Neurol2008; 21: 83–6.
173.
NichkovaMWynveenPMMarcDTHuismanHKellermannGH. Validation of an ELISA for urinary dopamine: applications in monitoring treatment of dopamine-related disorders. J Neurochem2013; 125: 724–35.
174.
BolnerAPilleriMDe RivaVNorderaGP. Plasma and urinary HPLC-ED determination of the ratio of 8-OHdG/2-dG in Parkinson’s disease. Clin Lab2011; 57: 859–66.
175.
LeeCYSeetRCHuangSHLongLHHalliwellB. Different patterns of oxidized lipid products in plasma and urine of dengue fever, stroke, and Parkinson’s disease patients: cautions in the use of biomarkers of oxidative stress. Antioxid Redox Signal2009; 11: 407–20.
176.
BarbadoJMartinDVegaLAlmansaRGoncalvesLNocitoMJimenoAOrtiz de LejarazuRBermejo-MartinJF. MCP-1 in urine as biomarker of disease activity in systemic lupus erythematosus. Cytokine2012; 60: 583–6.
177.
YangCCHsiehSCLiKJWuCHLuMCTsaiCYYuCL. Urinary neutrophil gelatinase-associated lipocalin is a potential biomarker for renal damage in patients with systemic lupus erythematosus. J Biomed Biotechnol2012; 2012: 759313–759313.
178.
JungKLeinM. Bone turnover markers in serum and urine as diagnostic, prognostic and monitoring biomarkers of bone metastasis. Biochim Biophys Acta2014; 1846: 425–38.
179.
GarneroPBuchsNZekriJRizzoliRColemanREDelmasPD. Markers of bone turnover for the management of patients with bone metastases from prostate cancer. Br J Cancer2000; 82: 858–64.
180.
TavintharanSPekLTLiuJJNgXWYeohLYSu ChiLChee FangS. Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus. Diabetes Vasc Dis Res2014; 11: 359–62.
181.
OhKWRheeEJLeeWYKimSWOhESBaekKHKangMIChoiMGYooHJParkSW. The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women. Clin Endocrinol2004; 61: 244–9.
182.
WatanabeTSuzuyaHOnishiTKanaiSKanekoMWatanabeHNakagawaRKawanoYTakaueYKurodaYTalmadgeJE. Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization. Int J Hematol2003; 77: 75–81.
183.
MesaFMagan-FernandezAMunozRPapay-RamirezLPoyatosRSanchez-FernandezEGalindo-MorenoPRodríguez-BarrancoM. Catecholamine metabolites in urine, as chronic stress biomarkers, are associated with higher risk of chronic periodontitis in adults. J Periodontol2014; 85: 1755–62.
184.
SlobodovGFeloneyMGranCKykerKDHurstRECulkinDJ. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol2004; 171: 1554–8.
185.
KeaySZhangCOKagenDIHiseMKJacobsSCHebelJRGordonDWhitmoreKBodisonSWarrenJW. Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls. J Urol1997; 158: 1983–8.
186.
ByrneDSSedorJFEstojakJFitzpatrickKJChiuraANMulhollandSG. The urinary glycoprotein GP51 as a clinical marker for interstitial cystitis. J Urol1999; 161: 1786–90.
187.
ZengYWuXXHommaYYoshimuraNIwakiHKageyamaSYoshikiTKakehiY. Uroplakin III-delta4 messenger RNA as a promising marker to identify nonulcerative interstitial cystitis. J Urol2007; 178: 1322–7; discussion 7.
188.
HauserPJDozmorovMGBaneBLSlobodovGCulkinDJHurstRE. Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis. J Urol2008; 179: 764–9.
189.
SabanRSabanMRMaierJFowlerBTengowskiMDavisCAWuXRCulkinDJHauserPBackerJHurstRE. Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients. Am J Physiol Ren Physiol2008; 295: F1613–23.
190.
LotzMVilligerPHugliTKoziolJZurawBL. Interleukin-6 and interstitial cystitis. J Urol1994; 152: 869–73.
191.
JacobsBLSmaldoneMCTyagiVPhilipsBJJackmanSVLengWWTyagiP. Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients. Can J Urol2010; 17: 4989–94.
192.
KeaySKZhangCOShoenfeltJEricksonDRWhitmoreKWarrenJWMarvelRChaiT. Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology2001; 57: 9–14.
193.
YoungBLMlamlaZGqamanaPPSmitSRobertsTPeterJTheronGGovenderUDhedaKBlackburnJ. The identification of tuberculosis biomarkers in human urine samples. Eur Respir J2014; 43: 1719–29.
194.
WongSYCabodiMRollandJKlapperichCM. Evaporative concentration on a paper-based device to concentrate analytes in a biological fluid. Anal Chem2014; 86: 11981–5.
195.
FortunJMartin-DavilaPGomez-MampasoEGonzalez-GarciaABarbollaIGomez-GarciaIWikmanPOrtízJNavasECuarteroCGijónDMorenoS. Extra-pulmonary tuberculosis: differential aspects and role of 16S-rRNA in urine. Int J Tuberc Lung Dis2014; 18: 478–85.
196.
PollockNRMacoveiLKanunfreKDhimanRRestrepoBIZarateIPinoPAMora-GuzmanFFujiwaraRTMichelGKashinoSSCampos-NetoA. Validation of Mycobacterium tuberculosis Rv1681 protein as a diagnostic marker of active pulmonary tuberculosis. J Clin Microbiol2013; 51: 1367–73.
197.
ShiJWangZLiHYuanH. Diagnostic performance of the urinary deoxypyridinoline in spinal tuberculosis. Orthopedics2012; 35: e922–6.
198.
CannasACalvoLChiacchioTCuzziGVaniniVLauriaFNPucciLGirardiEGolettiD. IP-10 detection in urine is associated with lung diseases. BMC Infect Dis2010; 10: 333–333.
199.
HorakEGassnerISolderBWachterHFuchsD. Neopterin levels and pulmonary tuberculosis in infants. Lung1998; 176: 337–44.
200.
SofiaMMormileMFaraoneSAlifanoMCarratuPCarratuL. Endothelin-1 excretion in urine in active pulmonary sarcoidosis and in other interstitial lung diseases. Sarcoidosis1995; 12: 118–23.
201.
LiuKDYangWGoASAndersonAHFeldmanHIFischerMJHeJKallemRRKusekJWMasterSRMillerER3rdRosasSESteigerwaltSTaoKWeirMRHsuCY. CRIC Study Investigators. Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis2015; 65: 267–74.
202.
PalominoHLRifkinDEAndersonCCriquiMHWhooleyMAIxJH. 24-hour urine phosphorus excretion and mortality and cardiovascular events. Clin J Am Soc Nephrol2013; 8: 1202–10.
203.
CarterCEGansevoortRTSchevenLHeerspinkHJShlipakMGde JongPEIxJH. Influence of urine creatinine on the relationship between the albumin-to-creatinine ratio and cardiovascular events. Clin J Am Soc Nephrol2012; 7: 595–603.
204.
TofikRTorffvitORippeBBakoushO. Increased urine IgM excretion predicts cardiovascular events in patients with type 1 diabetes nephropathy. BMC Med2009; 7: 39–39.
205.
ChristiansenMSHommelEMagidEFeldt-RasmussenB. Orosomucoid in urine is a powerful predictor of cardiovascular mortality in normoalbuminuric patients with type 2 diabetes at five years of follow-up. Diabetologia2005; 48: 386–93.
206.
OsakiMKosakaNOkadaFOchiyaT. Circulating microRNAs in drug safety assessment for hepatic and cardiovascular toxicity: the latest biomarker frontier?Mol Diagn Ther2014; 18: 121–6.
207.
BrachaSMcNamaraMHilgartIMilovancevMMedlockJGoodallCWickramasekaraSMaierCS. A multiplex biomarker approach for the diagnosis of transitional cell carcinoma from canine urine. Anal Biochem2014; 455: 41–7.
208.
ChengDLiangBLiY. Clinical value of vascular endothelial growth factor and endostatin in urine for diagnosis of bladder cancer. Tumori2012; 98: 762–7.
209.
Da PieveCSahgalNMooreSAVelasco-GarciaMN. Development of a liquid chromatography/tandem mass spectrometry method to investigate the presence of biomarkers of DNA damage in urine related to red meat consumption and risk of colorectal cancer. Rapid Commun Mass Spectrom2013; 27: 2493–503.
210.
BarocasDAMotleySCooksonMSChangSSPensonDFDaiQMilneGRobertsLJ2ndMorrowJConcepcionRSSmithJAJrFowkeJH. Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer. J Urol2011; 185: 2102–7.
211.
LafuenteARodriguezAGibanelRLafuenteMJAlonsoMMolinaRBallestaACarreteroP. Limitations in the use of glutathione S-transferase P1 in urine as a marker for bladder cancer. Anticancer Res1998; 18: 3771–2.
212.
WrightMEMichaudDSPietinenPTaylorPRVirtamoJAlbanesD. Estimated urine pH and bladder cancer risk in a cohort of male smokers (Finland). Cancer Causes Control2005; 16: 1117–23.
213.
HenningSMWangPAbgaryanNVicinanzaRde OliveiraDMZhangYLeeRPCarpenterCLAronsonWJHeberD. Phenolic acid concentrations in plasma and urine from men consuming green or black tea and potential chemopreventive properties for colon cancer. Mol Nutr Food Res2013; 57: 483–93.
214.
TurnerGAEllisRDGuthrieDLatnerALMonaghanJMRossWMSkillenAWWilsonRG. Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic GMP: a potential marker for cancer treatment. J Clin Pathol1982; 35: 800–6.
215.
De JongWHDe BoerECVan der MeijdenAPVegtPSteerenbergPADebruyneFMRuitenbergEJ. Presence of interleukin-2 in urine of superficial bladder cancer patients after intravesical treatment with bacillus Calmette-Guerin. Cancer Immunol Immunother1990; 31: 182–6.
216.
de BoerECde JongWHvan der MeijdenAPSteerenbergPAWitjesFVegtPDDebruyneFMRuitenbergEJ. Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis. Urol Res1991; 19: 45–50.
217.
BenedictWFFisherMZhangXQYangZMunsellMFDinneyCN. Use of monitoring levels of soluble forms of cytokeratin 18 in the urine of patients with superficial bladder cancer following intravesical Ad-IFNalpha/Syn3 treatment in a phase l study. Cancer Gene Ther2014; 21: 91–4.
218.
MaLChenJWangRHanYZhangJDongWZhangXWuYZhaoZ. The level of Alzheimer-associated neuronal thread protein in urine may be an important biomarker of mild cognitive impairment. J Clin Neurosci2015; 22: 649–52.
219.
LibertFCoudoreFRichardDDurifFEschalierA. Development of a gas chromatographic/mass spectrometric method to quantify R(-)-apomorphine, R(-)-apocodeine and R(-)-norapomorphine in human plasma and urine. J Mass Spectrom2005; 40: 1521–5.
220.
AndrewRWatsonDGBestSAMidgleyJMWenlongHPettyRK. The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls. Neurochem Res1993; 18: 1175–7.
221.
GolasikMWodowskiGGomolkaEHermanMPiekoszewskiW. Urine as a material for evaluation of exposure to manganese in methcathinone users. J Trace Elem Med Biol2014; 28: 338–43.
222.
BispoJAde Sousa VieiraEESilveiraLJrFernandesAB. Correlating the amount of urea, creatinine, and glucose in urine from patients with diabetes mellitus and hypertension with the risk of developing renal lesions by means of Raman spectroscopy and principal component analysis. J Biomed Opt2013; 18: 87004–87004.
223.
YangYXiaoLLiJKanwarYSLiuFSunL. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy. Med Hypotheses2013; 81: 274–8.
224.
BhensdadiaNMHuntKJLopes-VirellaMFMichael TuckerJMatariaMRAlgeJLNeelyBAJanechMGArthurJM. Veterans Affairs Diabetes Trial (VADT) study group. Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes. Kidney Int2013; 83: 1136–43.
225.
SawanyawisuthKLimpawattanaPMahankkanukrauhAWongvipapornC. The rate of checking urine microalbumin and aspirin primary prevention in type 2 DM. J Med Assoc Thai2006; 89: 626–31.
226.
SchroederAHeiderhoffMKobberlingJ. Determination of albuminuria in the urine of diabetics for prevention and control of diabetic nephropathy. GMS Health Technol Assess2005; 1: Doc04–Doc04.
227.
OxlundCSBuhlKBJacobsenIAHansenMRGramJHenriksenJESchousboeKTarnowLJensenBL. Amiloride lowers blood pressure and attenuates urine plasminogen activation in patients with treatment-resistant hypertension. J Am Soc Hypertens2014; 8: 872–81.
228.
MatsaRAshleyESharmaVWaldenAPKeatingL. Plasma and urine neutrophil gelatinase-associated lipocalin in the diagnosis of new onset acute kidney injury in critically ill patients. Crit Care2014; 18: R137–R137.
229.
KaSMTsaiPYChaoTKYangSMHungYJChenJSShuiHAChenA. Urine annexin A1 as an index for glomerular injury in patients. Dis Markers2014; 2014: 854163–854163.
230.
PiscatorMThe nephropathy of chronic cadmium poisoning. In: FoulkesEC (ed). Cadmium, New York, NY: Springer-Verlag, 1986, pp. 179–94.
WangLLiuHYShiHHLangJHSunW. Urine peptide patterns for non-invasive diagnosis of endometriosis: a preliminary prospective study. Eur J Obstet Gynecol Reprod Biol2014; 177: 23–8.
233.
SylvesterKGLingXBLiuGYKastenbergZJJiJHuZWuSPengSAbdullahFBrandtMLEhrenkranzRAHarrisMCLeeTCSimpsonBJBowersCMossRL. Urine protein biomarkers for the diagnosis and prognosis of necrotizing enterocolitis in infants. J Pediatr2014; 164: 607–12 e1-7.
234.
KimmelDWLeBlancGMeschievitzMECliffelDE. Electrochemical sensors and biosensors. Anal Chem2012; 84: 685–707.
235.
ChenAChatterjeeS. Nanomaterials based electrochemical sensors for biomedical applications. Chem Soc Rev2013; 42: 5425–38.
236.
GorodkiewiczEGuszczTRoszkowska-JakimiecWKozlowskiR. Cathepsin D serum and urine concentration in superficial and invasive transitional bladder cancer as determined by surface plasmon resonance imaging. Oncol Lett2014; 8: 1323–7.
237.
KhalidTWhitePDe Lacy CostelloBPersadREwenRJohnsonEProbertCSRatcliffeN. A pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace. PloS One2013; 8: e69602–e69602.
238.
HuangJKumarSAbbassi-GhadiNSpanelPSmithDHannaGB. Selected ion flow tube mass spectrometry analysis of volatile metabolites in urine headspace for the profiling of gastro-esophageal cancer. Anal Chem2013; 85: 3409–16.
239.
JagerTTschirdewahnSVom DorpFPiechottaGRubbenHSzarvasT. [Siliconchiptechnology-based MMP-7 analysis in urine: an option for preoperative identification of lymph node metastasis in bladder cancer]. Der Urologe Ausg A2013; 52: 853–8.
240.
MohanKDonavanKCArterJAPennerRMWeissGA. Sub-nanomolar detection of prostate-specific membrane antigen in synthetic urine by synergistic, dual-ligand phage. J Am Chem Soc2013; 135: 7761–7.
241.
BoyleJOMaoLBrennanJAKochWMEiseleDWSaundersJRSidranskyD. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg1994; 168: 429–32.
242.
WeiFLinCCJoonAFengZTrocheGLiraMEChiaDMaoMHoCLSuWCWongDT. Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer. Am J Respir Crit Care Med2014; 190: 1117–26.
243.
YangCYBrooksELiYDennyPHoCMQiFShiWWolinskyLWuBWongDTMontemagnoCD. Detection of picomolar levels of interleukin-8 in human saliva by SPR. Lab Chip2005; 5: 1017–23.
244.
TanWSabetLLiYYuTKlokkevoldPRWongDTHoCM. Optical protein sensor for detecting cancer markers in saliva. Biosens Bioelectron2008; 24: 266–71.
245.
JokerstJVRaamanathanAChristodoulidesNFlorianoPNPollardAASimmonsGWWongJGageCFurmagaWBReddingSWMcDevittJT. Nano-bio-chips for high performance multiplexed protein detection: determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels. Biosens Bioelectron2009; 24: 3622–9.
